ArticlePloS one2026
Vaccination scenario-based study on seasonal influenza in Republic of Korea.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSeasonal influenza presents a persistent threat to global health, with the elderly (65 + years) facing disproportionate risks of severe clinical outcomes. While the World Health Organization advocates for targeted immunization, the epidemiological impact of varying vaccination schedules remains a critical area for quantitative evaluation. This study investigates how the prioritization and temporal shifting of vaccine administration influence disease burden within the demographic context of Korea.
methodWe constructed an age-structured compartment model across four demographic groups (G1:0-14, G2:15-49, G3:50-64, and G4: 65+) using 2023-2024 seasonal influenza data in Korea. Among the various scenarios evaluated, we specifically performed an analysis by advancing the vaccination start date for the elderly group (G4) by up to two weeks to evaluate its comparative effectiveness against the baseline Korean National Immunization Program (KNIP). Furthermore, to quantify parameter uncertainty and assess the robustness of our model, we performed bootstrapping and partial rank correlation coefficient (PRCC) analyses.
resultsOur analysis reveals that, under the baseline vaccination strategy, the highest infection rates occur in the G1 age group, while early vaccination of the G4 group is found to be effective in reducing hospitalizations and deaths. Specifically, scenarios prioritizing early vaccination for the elderly (G4) with different immune states were associated with a 34.2% reduction in cumulative cases (range: 11.5-53.9%) and a 39.1% decrease in peak infection levels (range: 12.3-60.4%) compared to the baseline. Sensitivity analysis using PRCC showed that the symptomatic infectious period and G4 transmission parameters were identified as the primary drivers of cases and deaths.
conclusionThese findings suggest that targeted, timely vaccination of the elderly (65 + years) can contribute to mitigating the overall epidemic burden and alleviating periods of high hospital demand. Our simulation results indicate that age-specific strategies, particularly those accelerating vaccination for the elderly, offer a valuable quantitative framework for reducing the public health impact of seasonal influenza. While these outcomes are subject to model-specific assumptions, they provide a reasonable basis for further refining immunization programs within structured epidemic interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.